Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Sinclair Research will officially open its 20,000-square-foot laboratory expansion later this spring.
read more
Thermo Fisher Scientific has signed an agreement with Janssen Biotech to co-develop a companion diagnostic (CDx) in oncology.
read more
Clearside Biomedical announced Arctic Vision has acquired an exclusive license for the commercialization and development of XIPERE in Greater China and South Korea.
read more
Aldevron has hired Vijay Surapaneni as its Vice President of Biomanufacturing Operations. This is a new position and is a part of the senior management team.
read more
Wednesday, March 11, 2020
OptimizeRx has secured two additional enterprise-level engagements, expanding access for two clients across the entire OptimizeRx platform.
read more
Wednesday, March 11, 2020
HitGen and Kaken Pharmaceutical have entered into a license agreement to develop a novel class of drugs.
read more
Wednesday, March 11, 2020
The FDA and the FTC issued warning letters to seven companies for selling fraudulent COVID-19 products.
read more
Wednesday, March 11, 2020
Ajinomoto Bio-Pharma announced the formation of its External Advisory Board (EAB) to provide insight into industry trends and high-level advice to the Company’s leadership team.
read more
Wednesday, March 11, 2020
International Pharmaceutical Expo (INTERPHEX) will be postponed due to the COVID-19 virus.
read more
Wednesday, March 11, 2020
Burke Therapeutics has signed an exclusive marketing and supply agreement with Coeptis for the U.S. market.
read more
QPS announced the readiness of an access restricted bioanalysis lab prepared to analyze COVID-19 clinical trial samples.
read more
Today, we are providing an update on the status of U.S. Food and Drug Administration inspections outside of the U.S. in response to the COVID-19 outbreak.
read more
Bora Pharmaceuticals and GSK have entered into an agreement under which Bora Pharmaceuticals will acquire GSK's Mississauga, Ontario (Canada) facility.
read more
WindMIL Therapeutics have entered an agreement to expand WindMIL’s clinical manufacturing capacity.
read more
FUJIFILM Diosynth Biotechnologies has commenced the planned capacity expansion of its Flexible Biomanufacturing Facility at its College Station, Texas location.
read more